BMP1 and gout: Compared to current treatments for gout, such as nonsteroidal anti-inflammatory drugs and colchicine, therapeutic strategies targeting BMP-1 could provide more precise treatment options by directly regulating key pathways in uric acid metabolism and inflammatory response, potentially leading to more effective outcomes.